Statistics
Publications
4
Citations
160
H-Index
4
Active since
2023
Hengyuan Kou is an author at Nanjing Medical University specializing in molecular oncology, oncology, and medicine.
Publications per year
2023–2023
4
4
RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
Zhi Xu, Xiumei Wang, Wenbo Sun et al. · Redox Biology · 2023 · 68 citations · Full text
1–4 of 4